| Class | CCY | SZE(M) | WAL | MO | SP | FI | DR | KR | C/E | LTV | TYPE | BNCH | GDNC | SPRD | CPN | YLD | PRICE |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | USD | 266.250 | - | Aaa | AAA | - | - | - | - | - | Floating | 3mL | - | - | 3mL+157 | - | - |
| A | USD | 25.000 | - | - | AAA | - | - | - | - | - | - | - | - | - | - | - | - |
| B-1 | USD | 38.000 | - | - | AA | - | - | - | - | - | Floating | 3mL | - | - | 3mL+230 | - | - |
| B-2 | USD | 24.500 | - | - | AA | - | - | - | - | - | Floating | 3mL | - | - | 3mL+220 | - | - |
| C | USD | 46.250 | - | - | A | - | - | - | - | - | Floating | 3mL | - | - | 3mL+315 | - | - |
| D | USD | 32.500 | - | - | BBB- | - | - | - | - | - | Floating | 3mL | - | - | 3mL+435 | - | - |
| E-1 | USD | 16.500 | - | - | BB- | - | - | - | - | - | Floating | 3mL | - | - | 3mL+712 | - | - |
| E-2 | USD | 6.000 | - | - | BB- | - | - | - | - | - | Floating | 3mL | - | - | 3mL+725 | - | - |
| Equity | USD | 48.000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| F | USD | 12.500 | - | - | - | - | - | - | - | - | Floating | 3mL | - | - | 3mL+895 | - | - |
| X | USD | 2.000 | - | Aaa | AAA | - | - | - | - | - | Floating | 3mL | - | - | 3mL+100 | - | - |
Explore all other research.